Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
  1. 4 Open-market sale Director sold 149,700 shares at $15.75 ($2,357,775)
  2. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $11.07 ($110,700)
  3. 4 Open-market sale Director sold 71,371 shares at an average $10.12 ($722,299)
  4. 4 Open-market sale Director sold 1,898 shares at $9.01 ($17,101)
  5. 4 Open-market sale Director sold 201,731 shares at an average $8.42 ($1,697,614)
  6. 4 Open-market sale Director sold 7,500 shares at $8.13 ($60,975)
  7. 4 Open-market sale Chief Executive Officer sold 125,000 shares at $9.80 ($1,225,000)
  8. 4 Open-market sale Chief Financial Officer sold 7,990 shares at $9.96 ($79,580)
  9. 4 Open-market sale Chief Executive Officer sold 125,000 shares at $7.52 ($940,000)
  10. 4 Open-market sale Chief Financial Officer sold 30,000 shares at $7.22 ($216,600)
  11. 4 Open-market sale Director sold 10,000 shares at $6.81 ($68,072)
  12. 4 Open-market sale Director sold 7,500 shares at $6.40 ($48,000)
  13. 4 Open-market sale Chief Financial Officer sold 31,086 shares at $6.70 ($208,276)
  14. 4 Open-market sale Director sold 10,000 shares at $8.13 ($81,345)
  15. 4 Open-market sale Chief Financial Officer sold 31,000 shares at $7.00 ($217,000)
  16. 4 Open-market sale Director sold 68,185 shares at $8.86 ($604,119)
  17. 4 Open-market sale Chief Executive Officer sold 30,558 shares at an average $10.97 ($335,217)
  18. 4 Open-market sale Director sold 10,000 shares at $10.00 ($100,000)
  19. 4 Open-market sale Director sold 7,191 shares at $8.82 ($63,417)
  20. 4 Open-market sale Director sold 33,500 shares at an average $8.20 ($274,755)

Page 6 of 15 · 288 filings